Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 2/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 9/20 | 0.45 |
| ▸ | TP53 | P04637 | 6/20 | 0.45 |
| ▸ | POLB | P06746 | 3/20 | 0.45 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.41 |
| ▸ | PRF1 | P14222 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyclohexane SCHEMBL4200308 | 0.89 | PRF1 (0.41) | NPC1RAB9AMAPTTP53POLB | |
| SCHEMBL4190604 | 0.88 | NPC1 (0.39) | NPC1RAB9AMAPTTP53POLB | |
| SCHEMBL4193396 | 0.87 | KDM4E (0.37) | NPC1RAB9AMAPTTP53POLB | |
| SCHEMBL4193400 | 0.87 | KDM4E (0.37) | NPC1RAB9AMAPTTP53POLB | |
| Cyclopentane SCHEMBL4197408 | 0.78 | GHSR (0.49) | NPC1RAB9AMAPTTP53POLB | |
| Hydrochloric Acid SCHEMBL4197873 | 0.78 | PRF1 (0.37) | NPC1RAB9AMAPTTP53POLB | |
| SCHEMBL4188364 | 0.77 | POLB (0.35) | NPC1RAB9AMAPTTP53POLB | |
| Cyclohexane SCHEMBL4188186 | 0.76 | MMP13 (0.44) | NPC1RAB9AMAPTTP53POLB | |
| Cycloheptane SCHEMBL4204049 | 0.76 | PTGES2 (0.65) | NPC1RAB9AMAPTTP53POLB | |
| Cyclopentane SCHEMBL4192574 | 0.75 | RAB9A (0.52) | NPC1RAB9AMAPTTP53POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090215764-A1 | Antimicrobial agents | RANBAXY LABORATORIES LIMITED (IN) | 2009-08-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090215764-A1 | Antimicrobial agents | TUFM, RPS17, HARS1 | NPC1 1859/4885RAB9A 4342/4885MAPT 2269/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.